BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38918700)

  • 21. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR
    Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disrupted anatomic networks in the 22q11.2 deletion syndrome.
    Schmitt JE; Yi J; Calkins ME; Ruparel K; Roalf DR; Cassidy A; Souders MC; Satterthwaite TD; McDonald-McGinn DM; Zackai EH; Gur RC; Emanuel BS; Gur RE
    Neuroimage Clin; 2016; 12():420-8. PubMed ID: 27622139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
    Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.
    Tang SX; Moberg PJ; Yi JJ; Wiemken AS; Dress EM; Moore TM; Calkins ME; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE; Turetsky BI
    Schizophr Res; 2018 Dec; 202():113-119. PubMed ID: 30007867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders.
    Jalal R; Nair A; Lin A; Eckfeld A; Kushan L; Zinberg J; Karlsgodt KH; Cannon TD; Bearden CE
    J Neurodev Disord; 2021 Apr; 13(1):15. PubMed ID: 33863277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Source-based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome.
    Ge R; Ching CRK; Bassett AS; Kushan L; Antshel KM; van Amelsvoort T; Bakker G; Butcher NJ; Campbell LE; Chow EWC; Craig M; Crossley NA; Cunningham A; Daly E; Doherty JL; Durdle CA; Emanuel BS; Fiksinski A; Forsyth JK; Fremont W; Goodrich-Hunsaker NJ; Gudbrandsen M; Gur RE; Jalbrzikowski M; Kates WR; Lin A; Linden DEJ; McCabe KL; McDonald-McGinn D; Moss H; Murphy DG; Murphy KC; Owen MJ; Villalon-Reina JE; Repetto GM; Roalf DR; Ruparel K; Schmitt JE; Schuite-Koops S; Angkustsiri K; Sun D; Vajdi A; van den Bree M; Vorstman J; Thompson PM; Vila-Rodriguez F; Bearden CE
    Hum Brain Mapp; 2024 Jan; 45(1):e26553. PubMed ID: 38224541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline connectome modular abnormalities in the childhood phase of a longitudinal study on individuals with chromosome 22q11.2 deletion syndrome.
    Zhan L; Jenkins LM; Zhang A; Conte G; Forbes A; Harvey D; Angkustsiri K; Goodrich-Hunsaker NJ; Durdle C; Lee A; Schumann C; Carmichael O; Kalish K; Leow AD; Simon TJ
    Hum Brain Mapp; 2018 Jan; 39(1):232-248. PubMed ID: 28990258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.
    Armando M; Sandini C; Chambaz M; Schaer M; Schneider M; Eliez S
    Schizophr Bull; 2018 Oct; 44(suppl_2):S525-S535. PubMed ID: 29548017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study.
    Schaer M; Debbané M; Bach Cuadra M; Ottet MC; Glaser B; Thiran JP; Eliez S
    Schizophr Res; 2009 Dec; 115(2-3):182-90. PubMed ID: 19836927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Cortical Morphometry in the 22q11.2 Deletion Syndrome.
    Schmitt JE; Vandekar S; Yi J; Calkins ME; Ruparel K; Roalf DR; Whinna D; Souders MC; Satterwaite TD; Prabhakaran K; McDonald-McGinn DM; Zackai EH; Gur RC; Emanuel BS; Gur RE
    Biol Psychiatry; 2015 Jul; 78(2):135-43. PubMed ID: 25555483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications.
    Debbané M; Glaser B; David MK; Feinstein C; Eliez S
    Schizophr Res; 2006 Jun; 84(2-3):187-93. PubMed ID: 16545541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrinsic Connectivity Network-Based Classification and Detection of Psychotic Symptoms in Youth With 22q11.2 Deletions.
    Schreiner M; Forsyth JK; Karlsgodt KH; Anderson AE; Hirsh N; Kushan L; Uddin LQ; Mattiacio L; Coman IL; Kates WR; Bearden CE
    Cereb Cortex; 2017 Jun; 27(6):3294-3306. PubMed ID: 28383675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical Dysconnectivity Measured by Structural Covariance Is Associated With the Presence of Psychotic Symptoms in 22q11.2 Deletion Syndrome.
    Sandini C; Scariati E; Padula MC; Schneider M; Schaer M; Van De Ville D; Eliez S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):433-442. PubMed ID: 29735153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.
    Mancini V; Sandini C; Padula MC; Zöller D; Schneider M; Schaer M; Eliez S
    Mol Psychiatry; 2020 Nov; 25(11):2844-2859. PubMed ID: 31164700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome.
    Montojo CA; Ibrahim A; Karlsgodt KH; Chow C; Hilton AE; Jonas RK; Vesagas TK; Bearden CE
    Neuroimage Clin; 2014; 4():392-402. PubMed ID: 24567911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.
    Kikinis Z; Cho KIK; Coman IL; Radoeva PD; Bouix S; Tang Y; Eckbo R; Makris N; Kwon JS; Kubicki M; Antshel KM; Fremont W; Shenton ME; Kates WR
    Brain Imaging Behav; 2017 Oct; 11(5):1353-1364. PubMed ID: 27730479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Craniofacial features of 3q29 deletion syndrome: Application of next-generation phenotyping technology.
    Mak BC; Sanchez Russo R; Gambello MJ; Fleischer N; Black ED; Leslie E; Murphy MM; ; Mulle JG
    Am J Med Genet A; 2021 Jul; 185(7):2094-2101. PubMed ID: 33938623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.
    Chun S; Du F; Westmoreland JJ; Han SB; Wang YD; Eddins D; Bayazitov IT; Devaraju P; Yu J; Mellado Lagarde MM; Anderson K; Zakharenko SS
    Nat Med; 2017 Jan; 23(1):39-48. PubMed ID: 27892953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.
    Heller C; Weiss T; Del Re EC; Swago S; Coman IL; Antshel KM; Fremont W; Bouix S; Kates WR; Kubicki MR; Kikinis Z
    Psychiatry Res; 2021 Jul; 301():113979. PubMed ID: 33993037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural substrates of psychosis revealed by altered dependencies between brain activity and white-matter architecture in individuals with 22q11 deletion syndrome.
    Bortolin K; Delavari F; Preti MG; Sandini C; Mancini V; Mullier E; Van De Ville D; Eliez S
    Neuroimage Clin; 2022; 35():103075. PubMed ID: 35717884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.